Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company s wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.
Strides Pharma Science Ltd today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Potassium Chloride Oral Solution USP, 40 from the USFDA.